| Wed, Dec 2, 2009 | | | Orphan Drug Status for BioMarin Drug Zacks.com (Wed, Dec 2)
| | Tue, Dec 1, 2009 | | | Pfizer Takes In an Orphan on the Cheap at Motley Fool (Tue, Dec 1)
| | Mon, Nov 30, 2009 | | | BioMed Updates: Merck KGaA, BioMarin, Cytori and Theravance at Seeking Alpha (Mon, Nov 30)
| | | UPDATE - BioMarin autoimmune disease drug gets orphan status at Reuters (Mon, Nov 30)
| | | BioMarin treatment gets special FDA status AP (Mon, Nov 30)
| | | FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS PR Newswire (Mon, Nov 30)
| | Sat, Nov 28, 2009 | | | Less Toxic Monoclonal Antibodies And Increased Patent Protection For Biologics Creates Multiple Positive Investment Scenarios In Biotechnology Sector Wall Street Transcript (Sat, Nov 28)
| | Fri, Nov 27, 2009 | | | The Next Million-Dollar Penny Stock at Motley Fool (Fri, Nov 27)
| | Tue, Nov 24, 2009 | | | BioMarin to Present at the NASDAQ OMX 23rd Investor Program PR Newswire (Tue, Nov 24)
| | Fri, Nov 13, 2009 | | | Particles Detected in Vials from Genzyme's Plant Not Expected to Impact Aldurazyme or Naglazyme PR Newswire (Fri, Nov 13)
| | Mon, Nov 9, 2009 | | | Healthcare Bill Will Be Law By New Year Says Morningstar Strategist Wall Street Transcript (Mon, Nov 9)
| | Thu, Nov 5, 2009 | | | United States Patent Office Issues Patent Covering the Approved Administration of Kuvan With Food PR Newswire (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | | BioMarin to Present at the Credit Suisse Healthcare Conference PR Newswire (Wed, Nov 4)
| | Tue, Nov 3, 2009 | | | BIOMARIN PHARMACEUTICAL INC Financials EDGAR Online Financials (Tue, Nov 3)
| | Mon, Nov 2, 2009 | | | Finally Convinced? Benlysta Works! at Motley Fool (Mon, Nov 2)
| | Fri, Oct 30, 2009 | | | Earnings? Yawn. Trial Data? Moving! at Motley Fool (Fri, Oct 30)
| | | This Week's 5 Smartest Stock Moves at Motley Fool (Fri, Oct 30)
| | Thu, Oct 29, 2009 | | | BIOMARIN PHARMACEUTICAL INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Thu, Oct 29)
| | | Small and Volatile, but Not for Long at Motley Fool (Thu, Oct 29)
| | | Biotech Stocks: BioMarin, Human Genome lead drug stocks higher at MarketWatch (Thu, Oct 29)
| Add BMRN News to My Yahoo!:

| |
|